Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4133283 | 0.94 | SLC6A9 (0.86) | SLC6A9SLC6A5 | |
| SCHEMBL9882765 | 0.94 | SLC6A9 (0.86) | SLC6A9SLC6A5 | |
| SCHEMBL4125765 | 0.93 | SLC6A9 (0.84) | SLC6A9SLC6A5 | |
| SCHEMBL9882758 | 0.93 | SLC6A9 (0.84) | SLC6A9SLC6A5 | |
| SCHEMBL4127995 | 0.91 | SLC6A9 (0.81) | SLC6A9SLC6A5 | |
| SCHEMBL9882762 | 0.91 | SLC6A9 (0.81) | SLC6A9SLC6A5 | |
| SCHEMBL1461287 | 0.90 | SLC6A9 (0.82) | SLC6A9SLC6A5 | |
| SCHEMBL9882774 | 0.90 | SLC6A9 (0.82) | SLC6A9SLC6A5 | |
| SCHEMBL4524326 | 0.90 | SLC6A9 (0.82) | SLC6A9SLC6A5 | |
| SCHEMBL9882773 | 0.90 | SLC6A9 (0.82) | SLC6A9SLC6A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8188139-B2 | Heterocyclic-substituted phenyl methanones | HOFFMAN-LA ROCHE INC. (US) | 2012-05-29 | — | — | US | disclosed |
| US-20090203665-A1 | HETEROCYCLIC-SUBSTITUTED PHENYL METHANONES | JOLIDON SYNESE | 2009-08-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090203665-A1 | HETEROCYCLIC-SUBSTITUTED PHENYL METHANONES | CYP2B6, CYP2D6, CYP1A2 | SLC6A9 1024/4885SLC6A5 639/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.